Cargando…
Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN)
OBJECTIVE: To compare the recurrence rates after complete response to topical treatment with either cidofovir or imiquimod for vulval intraepithelial neoplasia (VIN) 3. DESIGN: A prospective, open, randomised multicentre trial. SETTING: 32 general hospitals located in Wales and England. POPULATION O...
Autores principales: | Hurt, CN, Jones, SEF, Madden, T‐A, Fiander, A, Nordin, AJ, Naik, R, Powell, N, Carucci, M, Tristram, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055842/ https://www.ncbi.nlm.nih.gov/pubmed/29336101 http://dx.doi.org/10.1111/1471-0528.15124 |
Ejemplares similares
-
Combined HPV 16 E2 and L1 methylation predict response to treatment with cidofovir and imiquimod in patients with vulval intraepithelial neoplasia
por: Hurt, Christopher Nicholas, et al.
Publicado: (2022) -
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
por: Daayana, S, et al.
Publicado: (2010) -
p53 codon 72 polymorphism in vulval cancer and vulval intraepithelial neoplasia
por: Rosenthal, A N, et al.
Publicado: (2000) -
Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma
por: Rosenthal, A N, et al.
Publicado: (2003) -
AKT1 Loss Correlates with Episomal HPV16 in Vulval Intraepithelial Neoplasia
por: Ekeowa-Anderson, Arucha L., et al.
Publicado: (2012)